Affinity Asset Advisors, LLC Savara Inc Transaction History
Affinity Asset Advisors, LLC
- $579 Million
- Q3 2024
A detailed history of Affinity Asset Advisors, LLC transactions in Savara Inc stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 700,000 shares of SVRA stock, worth $2.27 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
700,000
Previous 1,546,850
54.75%
Holding current value
$2.27 Million
Previous $6.23 Million
52.38%
% of portfolio
0.51%
Previous 0.85%
Shares
3 transactions
Others Institutions Holding SVRA
# of Institutions
129Shares Held
158MCall Options Held
67.6KPut Options Held
29.4K-
Nea Management Company, LLC Timonium, MD24.5MShares$79.3 Million7.93% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$47.2 Million11.08% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$40.1 Million6.8% of portfolio
-
Wellington Management Group LLP Boston, MA8.62MShares$27.9 Million0.01% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.16MShares$26.4 Million1.86% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $369M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.